EP Wealth Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Sell
6,745
-1,111
-14% -$231K 0.01% 633
2026
Q1
$1.66M Sell
7,856
-1,523
-16% -$328K 0.01% 514
2025
Q4
$1.93M Buy
+9,379
New +$1.77M 0.01% 457
2025
Q2
$871K Buy
5,185
+222
+4% +$32.9K 0.01% 593
2025
Q1
$684K Sell
4,963
-375
-7% -$47.8K 0.01% 602
2024
Q4
$631K Buy
5,338
+225
+4% +$26.3K 0.01% 620
2024
Q3
$565K Sell
5,113
-390
-7% -$40.8K ﹤0.01% 651
2024
Q2
$541K Buy
5,503
+189
+4% +$19.3K 0.01% 518
2024
Q1
$595K Buy
5,314
+249
+5% +$26.9K 0.01% 480
2023
Q4
$511K Buy
5,065
+2,091
+70% +$207K 0.01% 484
2023
Q3
$258K Buy
+2,974
New +$269K ﹤0.01% 591

Other funds holding CAH

EP Wealth Advisors's CAH Position: Q2 2026 in Review

EP Wealth Advisors reduced its Cardinal Health (CAH) stake by 14% in Q2 2026, selling an estimated $231K and leaving 6,745 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #633.

EP Wealth Advisors first reported a position in CAH in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.93M in Q4 2025. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • EP Wealth Advisors held 6,745 shares of Cardinal Health worth $1.6M as of Q2 2026.
  • EP Wealth Advisors sold 1,111 Cardinal Health shares in Q2 2026, an estimated $231K.
  • Cardinal Health made up 0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #633 holding.
  • EP Wealth Advisors first reported a position in Cardinal Health in Q3 2023 and has held it in 11 quarters since.
  • EP Wealth Advisors's Cardinal Health position peaked at $1.93M in Q4 2025.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.